Morgan Stanley’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-96,149
Closed -$67.5K 7995
2024
Q1
$67.5K Sell
96,149
-687,723
-88% -$777K ﹤0.01% 6122
2023
Q4
$1.37M Buy
783,872
+627,582
+402% +$917K ﹤0.01% 5147
2023
Q3
$225K Buy
156,290
+16,930
+12% +$42.4K ﹤0.01% 5524
2023
Q2
$362K Sell
139,360
-1,505
-1% -$4.5K ﹤0.01% 5378
2023
Q1
$518K Sell
140,865
-57,296
-29% -$241K ﹤0.01% 5236
2022
Q4
$351K Sell
198,161
-12,067
-6% -$32.1K ﹤0.01% 5412
2022
Q3
$832K Sell
210,228
-124,034
-37% -$763K ﹤0.01% 4988
2022
Q2
$1.85M Sell
334,262
-9,545
-3% -$78.2K ﹤0.01% 4598
2022
Q1
$5.05M Buy
343,807
+229,800
+202% +$3.08M ﹤0.01% 3677
2021
Q4
$1.8M Sell
114,007
-58,401
-34% -$1.4M ﹤0.01% 4660
2021
Q3
$5.54M Sell
172,408
-9,261
-5% -$325K ﹤0.01% 3571
2021
Q2
$7.55M Buy
181,669
+45,641
+34% +$1.87M ﹤0.01% 3322
2021
Q1
$6.91M Buy
136,028
+120,666
+785% +$6.31M ﹤0.01% 3069
2020
Q4
$499K Buy
15,362
+2,262
+17% +$32.1K ﹤0.01% 5084
2020
Q3
$156K Sell
13,100
-6,607
-34% -$76.6K ﹤0.01% 5226
2020
Q2
$261K Buy
19,707
+16,855
+591% +$220K ﹤0.01% 4951
2020
Q1
$32K Buy
+2,852
New +$35K ﹤0.01% 5644
2019
Q2
Sell
-1
Closed 6786
2019
Q1
$0 Hold
1
﹤0.01% 6748
2018
Q4
$0 Buy
+1
New +$20 ﹤0.01% 6773
2018
Q1
Sell
-1
Closed 6727
2017
Q4
$0 Buy
+1
New +$19 ﹤0.01% 6683

Other funds holding DMTK

Morgan Stanley's DMTK Position: Q2 2024 in Review

Morgan Stanley sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 96,149 shares — an estimated $67.5K sold.

Morgan Stanley first reported a position in DMTK in Q4 2017 and held it in 20 quarters. The position peaked at $7.55M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Morgan Stanley reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 96,149 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $67.5K.
  • Morgan Stanley first reported a position in DermTech, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
  • Morgan Stanley's DermTech, Inc. Common Stock position peaked at $7.55M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.